Medical Device News Magazine

Dr. Karl Reyes Becomes the New Chief of Pediatric Cardiac Surgery at St. Joseph’s Children’s Hospital

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

June 26, 2020

Dr. Karl Reyes, is the new chief of pediatric cardiac surgery at St. Joseph’s Children’s Hospital, home to Tampa Bay’s only comprehensive congenital heart disease program.

Dr. Karl Reyes will work closely with hospital physicians, leadership and staff to ensure that the pediatric cardiac team continues to achieve the highest standards of safety and quality. The team’s surgical outcomes already exceed national benchmarks as reported by the Society of Thoracic Surgeons.

“We believe that low mortality and a short length of stay are cornerstones of the program quality,” said St. Joseph’s Children’s Hospital President Sarah Naumowich. “Dr. Reyes’ extensive experience as a cardiac surgeon and the compassion he has for his patients make him an excellent addition to our multidisciplinary team. He will help lead us to even greater accomplishments and growth.”

Dr. Reyes was eager to join the St. Joseph’s Children’s Hospital pediatric and congenital heart program.

“I am impressed with how the team of cardiologists, surgeons, intensivists and anesthesiologists work in such close collaboration to make all significant patient care decisions. This is a time-tested model that has been shown to deliver the best outcomes and gives patients and their families a very special experience,” Reyes said.

Dr. Reyes adds that he’s also excited about St. Joseph’s Children’s Hospital’s partnership with UPMC Children’s Hospital of Pittsburgh, which has one of the country’s best congenital heart programs according to U.S. News and World Report rankings.

“Together, we can take this program to an even greater level and provide the best care possible for patients with congenital heart disease in the Tampa Bay region and beyond.”

Dr. Reyes comes to Tampa from the Children’s Hospital of San Antonio, Texas where he served as an associate professor of Pediatric Cardiac Surgery at the Baylor College of Medicine. Prior to that, he worked at the UF Health Congenital Heart Center and served as an associate professor of surgery at the University of Florida College of Medicine.

Dr. Reyes also worked in his home country the Philippines prior to returning to the United States. He served as the head of Congenital Heart Surgery at St. Luke’s Medical Center and was instrumental in the organization of the St. Luke’s Center for Congenital Heart Disease, making it one of the country’s premier programs. Dr. Reyes and his team were first in the Philippines to successfully perform cardiac surgery for hypoplastic left heart syndrome, and to perform hybrid cardiac procedures such as intraoperative stenting and periventricular device closure for muscular ventricular septal defects. He was also responsible for deployment of the Philippines’ first Extracorporeal Membrane Oxygenation (ECMO) program.

Dr. Reyes graduated with honors from the University of the East College of Medicine in Quezon City, Philippines. His post-doctoral training included clinical fellowships at the Cleveland Clinic in thoracic and cardiovascular surgery and at Boston Children’s Hospital – Harvard Medical School in congenital cardiovascular surgery. In his last year, Dr. Reyes was chief fellow at the Cleveland Clinic and Boston Children’s Hospital.

In addition to his work, Dr. Reyes co-founded The Operation Heart Foundation which is a charitable organization that provides free care for infants and children with congenital heart disease in the Philippines. He also volunteers with Gift of Life International.

Dr. Reyes has extensive experience in treating patients with complex congenital heart defects in neonates, infants, children, and adults. His expertise includes neonatal heart surgery, repairing heart valves, single ventricle physiology, tetralogy of Fallot with pulmonary atresia, and adult congenital heart disease.

St. Joseph’s Children’s Hospital is excited about the experience, passion and enthusiasm Dr. Reyes brings to its pediatric cardiac program.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”